Urate handling in the human body

D Hyndman, S Liu, JN Miner - Current rheumatology reports, 2016 - Springer
Elevated serum urate concentration is the primary cause of gout. Understanding the
processes that affect serum urate concentration is important for understanding the etiology of …

Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug …

P Nahid, SE Dorman, N Alipanah… - Clinical infectious …, 2016 - academic.oup.com
Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

Uric acid en route to gout

W Zhang - Advances in Clinical Chemistry, 2023 - Elsevier
Gout and hyperuricemia (HU) have generated immense attention due to increased
prevalence. Gout is a multifactorial metabolic and inflammatory disease that occurs when …

Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre

CC Shu, CH Lee, MC Lee, JY Wang… - … journal of tuberculosis …, 2013 - ingentaconnect.com
BACKGROUND: Hepatotoxicity with first-line drugs, a major complication of anti-tuberculosis
treatment, has not been studied by time-dependent analysis. DESIGN: Adult patients …

Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used

JG Pasipanodya, T Gumbo - Antimicrobial agents and …, 2010 - Am Soc Microbiol
Antimicrobial pharmacokinetic-pharmacodynamic studies suggest that pyrazinamide doses
higher than those currently recommended may be more efficacious. However, high …

Therapeutic potential of thymoquinone against anti-tuberculosis drugs induced liver damage

A Jaswal, N Sinha, M Bhadauria, S Shrivastava… - Environmental …, 2013 - Elsevier
Hepatotoxicity is the most serious adverse effect related to tuberculosis treatment which
interrupts the successful completion of tuberculosis treatment. The purpose of this study was …

Effect of antituberculous drugs on serum uric acid and urine uric acid excretion

W Louthrenoo, S Hongsongkiat… - JCR: Journal of …, 2015 - journals.lww.com
Objectives The aim of this study was to determine the effect of antituberculous drugs on
serum uric acid (SUA), urine uric acid (UUA) excretion, and renal function. Methods Patients …

Les effets indésirables des antituberculeux: épidémiologie, mécanismes et conduite à tenir

K Aouam, A Chaabane, C Loussaïef… - Médecine et maladies …, 2007 - Elsevier
Résumé La tuberculose est une maladie infectieuse devenue aujourd'hui curable
moyennant un traitement médicamenteux bien conduit. Si l'efficacité des médicaments …

Les effets indésirables des antituberculeux; prise en charge

J Perriot, É Chambonnet, A Eschalier - Revue des maladies respiratoires, 2011 - Elsevier
Résumé La tuberculose, maladie infectieuse curable par un traitement antibiotique bien
conduit, demeure un enjeu majeur de santé publique à l'échelle planétaire. La stratégie …

Уровень мочевой кислоты в сыворотке крови у больных впервые выявленным туберкулезом легких с множественной лекарственной устойчивостью …

РЮ Абдуллаев, ОГ Комиссарова… - … и болезни легких, 2017 - tibl-journal.com
Аннотация Уровень мочевой кислоты (МК) в сыворотке крови изучен у 134 больных
впервые выявленным туберкулезом легких с множественной лекарственной …